Abstract
17β-Estradiol (E2) controls many aspects of human physiology, including development, reproduction and homeostasis, through regulation of the transcriptional activity of its cognate receptors (ERs). E2 induces profound, rapid effects on the conformation of ERs allowing them to dimerize and to translocate into the nucleus where specific hormone response elements present in DNA are recognized. ER-E2 complex can also function as a cytoplasmic signaling molecule eliciting other changes in cells. Such extra-nuclear or non-genomic signaling pathways are rapid and supposedly independent of transcription. The recent finding that ER also resides at plasma membrane have opened a new spectrum on E2 rapid signaling and raised several new concerns in the field of E2 biology. ERs are now considered as very mobile proteins continuously shuttling between protein targets located within various cellular compartments (e.g., membrane, nucleus). This allows E2 to generate different and synergic signal transduction pathways, which provide plasticity for cell response to E2. Understanding the molecular mechanisms by which ERs transduce E2 signals in target cells will allow to design new pharmacologic therapies aimed at the treatment of a variety of human diseases affecting the cardiovascular, reproductive, skeletal, and the nervous systems as well as the mammary gland.
Keywords: Estrogen receptor α, Estrogen receptor β, Estrogen receptor palmitoylation, Membrane association of estrogen receptors, 17β-Estradiol, Rapid signals
Current Signal Transduction Therapy
Title: Estrogen Receptor Signaling: Impact on Cell Functions
Volume: 4 Issue: 2
Author(s): Maria Marino and Filippo Acconcia
Affiliation:
Keywords: Estrogen receptor α, Estrogen receptor β, Estrogen receptor palmitoylation, Membrane association of estrogen receptors, 17β-Estradiol, Rapid signals
Abstract: 17β-Estradiol (E2) controls many aspects of human physiology, including development, reproduction and homeostasis, through regulation of the transcriptional activity of its cognate receptors (ERs). E2 induces profound, rapid effects on the conformation of ERs allowing them to dimerize and to translocate into the nucleus where specific hormone response elements present in DNA are recognized. ER-E2 complex can also function as a cytoplasmic signaling molecule eliciting other changes in cells. Such extra-nuclear or non-genomic signaling pathways are rapid and supposedly independent of transcription. The recent finding that ER also resides at plasma membrane have opened a new spectrum on E2 rapid signaling and raised several new concerns in the field of E2 biology. ERs are now considered as very mobile proteins continuously shuttling between protein targets located within various cellular compartments (e.g., membrane, nucleus). This allows E2 to generate different and synergic signal transduction pathways, which provide plasticity for cell response to E2. Understanding the molecular mechanisms by which ERs transduce E2 signals in target cells will allow to design new pharmacologic therapies aimed at the treatment of a variety of human diseases affecting the cardiovascular, reproductive, skeletal, and the nervous systems as well as the mammary gland.
Export Options
About this article
Cite this article as:
Marino Maria and Acconcia Filippo, Estrogen Receptor Signaling: Impact on Cell Functions, Current Signal Transduction Therapy 2009; 4 (2) . https://dx.doi.org/10.2174/157436209788167493
DOI https://dx.doi.org/10.2174/157436209788167493 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Advances on Neural Tube Defects with Special Reference to Valproic Acid
Endocrine, Metabolic & Immune Disorders - Drug Targets Epigenetic Modulation of Myocardial Angiogenic Balance: An Emerging Therapeutic Perspective for Adult Failing Heart
Current Angiogenesis (Discontinued) Appraisal of Nano-Lipidic Astaxanthin cum Thermoreversible Gel and its Efficacy in Haloperidol Induced Parkinsonism
Current Drug Delivery Renal-Protective Activity of Dried Gel of <i>Aloe barbadensis</i> (Elwa) on Gentamicin- Induced Nephrotoxicity in Albino Rats
Current Traditional Medicine Lectin-Like Oxidized Low Density Lipoprotein Receptor 1 (LOX-1) in Atherogenesis: A Brief Review
Current Medicinal Chemistry Editorial (Thematic Issue: Biochemical Targets and Biomarkers for Central Nervous System Protection and Monitoring)
CNS & Neurological Disorders - Drug Targets Advancement of Targeted Ultrasound Contrast Agents and their Applications in Molecular Imaging and Targeted Therapy
Current Pharmaceutical Design Antioxidative Peptides: Trends and Perspectives for Future Research
Current Medicinal Chemistry Free Radical Scavenger Edaravone Administration Protects against Tissue Plasminogen Activator Induced Oxidative Stress and Blood Brain Barrier Damage
Current Neurovascular Research The Effects of Creatine Supplementation and Physical Exercise on Traumatic Brain Injury
Mini-Reviews in Medicinal Chemistry Effect of Resveratrol and Tiron on the Inactivation of Glyceraldehyde-3- phosphate Dehydrogenase Induced by Superoxide Anion Radical
Current Medicinal Chemistry Rho Kinase Inhibitors: Potential Treatments for Diabetes and Diabetic Complications
Current Pharmaceutical Design Development of Monoclonal Antibodies that Inhibit Platelet Adhesion or Aggregation as Potential Anti-Thrombotic Drugs
Cardiovascular & Hematological Disorders-Drug Targets Disease-Induced Neuroinflammation and Depression
CNS & Neurological Disorders - Drug Targets Myocardial Protection Against Ischemia-Reperfusion Injury: Novel Approaches in Maintaining Homeostatic Stability in Blood
Recent Patents on Cardiovascular Drug Discovery Nuclear Factor κB and Adenosine Receptors: Biochemical and Behavioral Profiling
Current Neuropharmacology AMPK - Activated Protein Kinase and its Role in Energy Metabolism of the Heart
Current Cardiology Reviews The Effect of Pyrroloquinoline Quinone on Apoptosis and Autophagy in Traumatic Brain Injury
CNS & Neurological Disorders - Drug Targets Recent Patents on Biomarkers for AKI
Recent Patents on Biomarkers Biological Activities of Yarrow Species (Achillea spp.)
Current Pharmaceutical Design